Page 1 of Clinical Trials for Drug Tiotropium placebo, 118 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Tiotropium Respimat Pharmacokinetic Study in COPD
Last Updated: May 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
2
Recruiting
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: May 11, 2012
Condition(s): Chronic Obstructive Pulmonary Disease
3
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma
Last Updated: May 2, 2012
Condition(s): Asthma
4
Completed
Effect of Indacaterol on Inspiratory Capacity (IC)
Last Updated: April 2, 2012
Condition(s): Chronic Obstructive Pulmonary Disease
5
Completed
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: May 4, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
6
Completed
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients Suffering From Chronic Obstructive Pulmonary Disease II
Last Updated: May 4, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
7
Completed
Dynamic Hyperinflation and Tiotropium
Last Updated: June 19, 2009
Condition(s): COPD
8
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Last Updated: May 11, 2012
Condition(s): Asthma
9
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Last Updated: May 11, 2012
Condition(s): Asthma
10
Completed
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma
Last Updated: May 2, 2012
Condition(s): Asthma
11
Completed
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)
Last Updated: May 11, 2012
Condition(s): Asthma
12
Completed
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)
Last Updated: May 11, 2012
Condition(s): Asthma
13
Completed
Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.
Last Updated: May 2, 2012
Condition(s): Asthma
14
Completed
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
Last Updated: May 18, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
15
Completed
Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma
Last Updated: September 21, 2011
Condition(s): Asthma
16
Completed
A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma
Last Updated: February 8, 2012
Condition(s): Asthma
17
Completed
A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: July 22, 2011
Condition(s): Chronic Obstructive Pulmonary Disease
18
Terminated
Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol PE Capsule) in COPD
Last Updated: July 13, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
19
Terminated
Tiotropium/Salmeterol Inhalation Powder in COPD
Last Updated: July 14, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
20
Recruiting
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Last Updated: May 2, 2012
Condition(s): Asthma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Tiotropium+placebo

Page 1 of Clinical Trials for Drug Tiotropium placebo, 118 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About